Atlas Trials

Anti-recurrence Treatment of Postresection on HCC Patients With MVI Presence and Over-expression of ASPH

Clinical trial NCT02587884 · UNKNOWN

Trial details

NCT number
NCT02587884
Sponsor
Eastern Hepatobiliary Surgery Hospital
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Primary completion
2017-12-01
Enrollment
180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.